Compound 1242
Identifiers
- Canonical SMILES:
Cc1cccc(n1)-c1nc(C(O)=O)c(-c2cccc(Cl)c2)n1-c1cc(Cl)ccc1C
- InChi:
InChI=1S/C23H17Cl2N3O2/c1-13-9-10-17(25)12-19(13)28-21(15-6-4-7-16(24)11-15)20(23(29)30)27-22(28)18-8-3-5-14(2)26-18/h3-12H,1-2H3,(H,29,30)
- InChiKey:
IUJRZHJGDURMMO-UHFFFAOYSA-N
External links
![]() 67954163 |
External search
|
|
|
|
|
Bibliography (1)
Pharmacological data
| Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
|---|---|---|---|
| 1 | 0 | 0 | 0 |
Targets
| PPI family | Best activity | Diseases | MMoA |
|---|---|---|---|
| MDM2-Like / P53 | 6.92 | cancer | Inhibition |
Physicochemical filters
| Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
|---|---|---|---|---|
| Compliance | ||||
| MW | 437.07 g/mol | |||
| HBA | 5 | |||
| HBD | 1 | |||
| HBA + HBD | 6 | |||
| AlogP | 5.12 | |||
| TPSA | 68.01 | |||
| RB | 3 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
| Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
|---|---|---|---|---|
| 1 | 1 | 0 | 0 | 0 |
Pharmacological data
| Bibliography | Name | Target | Competition | Assay type | Assay name | Cell line | Activity type | Activity |
|---|---|---|---|---|---|---|---|---|
| WO2011023677 | 156 | MDM2 Q00987 |
|
Biochemical assay | Fluorescence Polarization | pIC50 (half maximal inhibitory concentration, -log10) | 6.92 |
| Ta | Structure | Name | Drugbank ID |
|---|---|---|---|
| 0.4566 | Miransertib | DB14982 | |
| 0.4420 | Ralimetinib | DB11787 | |
| 0.4404 | Azeliragon | DB12689 | |
| 0.4361 | Conivaptan | DB00872 | |
| 0.4324 | 2-(4-Chlorophenyl)-5-Quinoxalinecarboxamide | DB03509 | |
| 0.4215 | Olmesartan | DB00275 | |
| 0.4198 | N-6022 | DB12206 | |
| 0.4186 | Telmisartan | DB00966 | |
| 0.4170 | Flumazenil | DB01205 | |
| 0.4132 | Linsitinib | DB06075 | |
| 0.4110 | Iomazenil | DB14971 | |
| 0.4046 | Cimicoxib | DB05095 | |
| 0.4036 | 2-phenyl-1H-imidazole-4-carboxylic acid | DB07803 | |
| 0.4000 | Cyclopropyl-{4-[5-(3,4-Dichlorophenyl)-2-[(1-Methyl)-Piperidin]-4-Yl-3-Propyl-3h-Imidazol-4-Yl]-Pyrimidin-2-Yl}Amine | DB03084 | |
| 0.4000 | Selonsertib | DB14916 |




